Hepatitis: The silent killer

May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care providers about hepatitis vaccinations. Hepatitis is an inf...

May 20, 2024 | Monday | Reports
AlphaFold 3 Unleashed: Because Who Needs Scientists Anyway?

Google DeepMind and Isomorphic Labs have unveiled AlphaFold 3, a groundbreaking AI model poised to rewrite the rulebook on molecular biology and redefine t...

May 10, 2024 | Friday | News
New Dietary Guidelines Released to Combat Nutritional Challenges in India

The National Institute of Nutrition (NIN), under the Indian Council of Medical Research (ICMR), has released updated "Dietary Guide...

May 10, 2024 | Friday | Reports
Industry Titans Illuminate Path to Pharmaceutical Innovation at INTERPHEX 2024

Industry pioneers Maria Batalha, Kevin J. Bittorf, Matthew Mollan, and John Nadzam took center stage at INTERPHEX 2024 to share their expertise and insight...

April 17, 2024 | Wednesday | Expert Opinion
INTERPHEX 2024 Sheds Light on Cutting-Edge Solutions: Leveraging AI for Fraud Detection in Pharma

Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024  Attendees at INTERPHEX 2024 were treated to a t...

April 16, 2024 | Tuesday | News
Advancements in AI Revolutionize 3D Printed Tablet Formulation Design: Insights from Metin Celik's Presentation

Today, attendees at INTERPHEX 2024 were treated to an illuminating presentation by Metin Celiak, delving into the transformative potential of Artificial In...

April 16, 2024 | Tuesday | News
Breakthrough Cardiac Study Reveals Long-Term Impact on Post-Transplant Survival: A 2-Year Clinical Investigation Advancing Heart Preservation

Paragonix Technologies, Inc., a pioneer in organ transplant technologies and services, announces the annual release of the latest GUARDIAN-Heart Clinical R...

April 14, 2024 | Sunday | Reports
Merck Announces Positive Data on V116, a Promising Pneumococcal Vaccine for Adults

    The trials demonstrated V116's effectiveness in generating immune responses across all 21 serotypes covered by the vaccine in diverse adult...

March 20, 2024 | Wednesday | News
Labcorp's Latest Studies at SGO Meeting Herald New Era in Ovarian Cancer Biomarker Testing

In an effort to bridge testing gaps and facilitate targeted therapies for EOC patients, Labcorp conducted two seminal studies, illustrating the profound im...

March 18, 2024 | Monday | News
Sanofi's Amlitelimab Shows Long-Term Efficacy in Atopic Dermatitis Treatment, Shaping Future Therapeutic Strategies

  New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis Late-breaking dat...

March 11, 2024 | Monday | News
Catalent Publishes Fifth Annual Corporate Responsibility Report, Demonstrating Commitment to Sustainability and Social Impact

    One of the notable achievements in fiscal 2023 was Catalent's robust efforts to mitigate its environmental impact and combat climate ...

March 08, 2024 | Friday | News
Special Spotlight Report: GSK's COiMMUNITY Initiative Boosts Adult Vaccination Rates

  Rob Truckenmiller, Senior Vice President, Head of US Vaccines, GSK, emphasized the importance of collaborative efforts and fi...

March 08, 2024 | Friday | Reports
23andMe Releases New Genetic Reports on Breast, Colorectal, and Prostate Cancer Risk for Members

23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, released three new genetic reports for 23andMe+ members on breast...

March 06, 2024 | Wednesday | Reports
Catalent's Meteoric Rise as Novo Holdings Makes Groundbreaking Acquisition

In a landmark move within the life sciences sector, Novo Holdings has announced its acquisition of Catalent, Inc. in an all-cash transaction valued at $16....

February 08, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in